Plasma exosomes from Head and Neck Cancer Patients modulate Immune Checkpoint Receptors on T cells and attenuate the Efficacy of Immunotherapy in vitro.

MLA

Ludwig, Sonja, et al. “Plasma Exosomes from Head and Neck Cancer Patients Modulate Immune Checkpoint Receptors on T Cells and Attenuate the Efficacy of Immunotherapy in Vitro.” Laryngo-Rhino-Otologie, vol. 102, May 2023, pp. S247–48. EBSCOhost, https://doi.org/10.1055/s-0043-1767267.

APA

Ludwig, S., Schütz, J., Theodoraki, M.-N., Seiz, E., Jungbauer, F., Scherl, C., Lammert, A., Rotter, N., & Tengler, L. (2023). Plasma exosomes from Head and Neck Cancer Patients modulate Immune Checkpoint Receptors on T cells and attenuate the Efficacy of Immunotherapy in vitro. Laryngo-Rhino-Otologie, 102, S247–S248. https://doi.org/10.1055/s-0043-1767267

Chicago

Ludwig, Sonja, Julia Schütz, Marie-Nicole Theodoraki, Elena Seiz, Frederic Jungbauer, Claudia Scherl, Anne Lammert, Nicole Rotter, and Luisa Tengler. 2023. “Plasma Exosomes from Head and Neck Cancer Patients Modulate Immune Checkpoint Receptors on T Cells and Attenuate the Efficacy of Immunotherapy in Vitro.” Laryngo-Rhino-Otologie 102 (May): S247–48. doi:10.1055/s-0043-1767267.